BioCentury | Nov 16, 2018
Financial News

M Ventures leads $30M series A for RNA start-up Ribometrix

...M Ventures is the strategic venture arm of Merck KGaA (Xetra:MRK). Ribometrix Inc., Durham, N.C. Virginia Li RiboMed Biotechnologies Inc....
BioCentury | Oct 6, 2014
Finance

4Q14 Financial Markets Preview: 'Perfect world' - for now

Even as the major biotech indices creep toward new all-time highs, buysiders are hard-pressed to identify any major risks that could cause a downturn in the fourth quarter. At the same time, there are few...
BioCentury | Sep 26, 2014
Financial News

Ribomic falls on first day of trading

Ribomic Inc. (Tokyo:4591) fell Y398 (17%) to Y1,902 in its first day of trading on the Tokyo Stock Exchange's Mothers. Last week, Ribomic raised Y2.8 billion ($25.7 million) through the sale of 1.2 million shares...
BioCentury | Sep 22, 2014
Financial News

Ribomic completes IPO

Ribomic Inc. , Tokyo, Japan Business: Autoimmune, Chemistry, Supply/Service Date completed: 2014-09-16 Type: IPO Raised: Y2.8 billion ($25.7 million) Shares: 1.2 million Price: Y2,300 Shares after offering: 12.1 million Underwriters: Daiwa Securities Group; SMBC Nikko Securities;...
BioCentury | Sep 17, 2014
Financial News

Ribomic raises $25.7M in Japanese IPO

Ribomic Inc. (Tokyo:4591) raised Y2.8 billion ($25.7 million) through the sale of 1.2 million shares at Y2,300 in an IPO on the Tokyo Stock Exchange's Mothers. The price values the company at Y27.8 billion ($258.3...
BioCentury | Sep 15, 2014
Financial News

Ribomic amends IPO

Ribomic Inc. , Tokyo, Japan Business: Autoimmune, Chemistry, Supply/Service Date announced: 2014-09-08 Type: IPO To be raised: Up to Y2.8 billion ($26.2 million) Shares: 1.2 million Price: Y2,000-Y2,300 Underwriters: Daiwa Securities Group; SMBC Nikko Securities; Mizuho;...
BioCentury | Sep 15, 2014
Finance

Ribomic test in Tokyo

Ribomic Inc. hopes to become 2014's first biotech IPO on the Tokyo Stock Exchange this month. Last week, Ribomic set the price range at ¥2,000-¥2,300 for its IPO on the exchange's Mothers. If the aptamer...
BioCentury | Sep 9, 2014
Financial News

Ribomic sets IPO range

Ribomic Inc. (Tokyo, Japan) plans to sell 1.2 million shares at Y2,000-Y2,300 in its IPO on the Tokyo Stock Exchange's Mothers. At the Y2,150 midpoint Ribomic would raise Y2.6 billion ($24.5 million) and be valued...
BioCentury | Sep 1, 2014
Financial News

Ribomic proposes IPO

Ribomic Inc. , Tokyo, Japan Business: Autoimmune, Chemistry, Supply/Service Date announced: 2014-08-20 Type: IPO To be raised: Y2.7 billion ($26.3 million) Shares: 1.2 million Price: Y2,240 Underwriter: Daiwa Securities Group Overallotment: 324,600 Note: Ribomic is seeking...
BioCentury | Aug 22, 2014
Financial News

Ribomic planning Tokyo IPO

Ribomic Inc. (Tokyo, Japan) is planning to raise Y2.7 billion ($26.3 million) through the sale of 1.2 million shares on the Tokyo Stock Exchange's Mothers in an IPO underwritten by Daiwa Securities and six other...
Items per page:
1 - 10 of 14
BioCentury | Nov 16, 2018
Financial News

M Ventures leads $30M series A for RNA start-up Ribometrix

...M Ventures is the strategic venture arm of Merck KGaA (Xetra:MRK). Ribometrix Inc., Durham, N.C. Virginia Li RiboMed Biotechnologies Inc....
BioCentury | Oct 6, 2014
Finance

4Q14 Financial Markets Preview: 'Perfect world' - for now

Even as the major biotech indices creep toward new all-time highs, buysiders are hard-pressed to identify any major risks that could cause a downturn in the fourth quarter. At the same time, there are few...
BioCentury | Sep 26, 2014
Financial News

Ribomic falls on first day of trading

Ribomic Inc. (Tokyo:4591) fell Y398 (17%) to Y1,902 in its first day of trading on the Tokyo Stock Exchange's Mothers. Last week, Ribomic raised Y2.8 billion ($25.7 million) through the sale of 1.2 million shares...
BioCentury | Sep 22, 2014
Financial News

Ribomic completes IPO

Ribomic Inc. , Tokyo, Japan Business: Autoimmune, Chemistry, Supply/Service Date completed: 2014-09-16 Type: IPO Raised: Y2.8 billion ($25.7 million) Shares: 1.2 million Price: Y2,300 Shares after offering: 12.1 million Underwriters: Daiwa Securities Group; SMBC Nikko Securities;...
BioCentury | Sep 17, 2014
Financial News

Ribomic raises $25.7M in Japanese IPO

Ribomic Inc. (Tokyo:4591) raised Y2.8 billion ($25.7 million) through the sale of 1.2 million shares at Y2,300 in an IPO on the Tokyo Stock Exchange's Mothers. The price values the company at Y27.8 billion ($258.3...
BioCentury | Sep 15, 2014
Financial News

Ribomic amends IPO

Ribomic Inc. , Tokyo, Japan Business: Autoimmune, Chemistry, Supply/Service Date announced: 2014-09-08 Type: IPO To be raised: Up to Y2.8 billion ($26.2 million) Shares: 1.2 million Price: Y2,000-Y2,300 Underwriters: Daiwa Securities Group; SMBC Nikko Securities; Mizuho;...
BioCentury | Sep 15, 2014
Finance

Ribomic test in Tokyo

Ribomic Inc. hopes to become 2014's first biotech IPO on the Tokyo Stock Exchange this month. Last week, Ribomic set the price range at ¥2,000-¥2,300 for its IPO on the exchange's Mothers. If the aptamer...
BioCentury | Sep 9, 2014
Financial News

Ribomic sets IPO range

Ribomic Inc. (Tokyo, Japan) plans to sell 1.2 million shares at Y2,000-Y2,300 in its IPO on the Tokyo Stock Exchange's Mothers. At the Y2,150 midpoint Ribomic would raise Y2.6 billion ($24.5 million) and be valued...
BioCentury | Sep 1, 2014
Financial News

Ribomic proposes IPO

Ribomic Inc. , Tokyo, Japan Business: Autoimmune, Chemistry, Supply/Service Date announced: 2014-08-20 Type: IPO To be raised: Y2.7 billion ($26.3 million) Shares: 1.2 million Price: Y2,240 Underwriter: Daiwa Securities Group Overallotment: 324,600 Note: Ribomic is seeking...
BioCentury | Aug 22, 2014
Financial News

Ribomic planning Tokyo IPO

Ribomic Inc. (Tokyo, Japan) is planning to raise Y2.7 billion ($26.3 million) through the sale of 1.2 million shares on the Tokyo Stock Exchange's Mothers in an IPO underwritten by Daiwa Securities and six other...
Items per page:
1 - 10 of 14